Analytical Data
-
Gene name
CHID1
- Application
-
Alternative Names
Chid1Chitinase domain-containing protein 1
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q922Q9
-
Expression Region
20-393aa
-
Molecular Weight
46.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CHID1, or "Chromosomal Instability and DNA Damage Response 1," is a protein that has emerged as a significant focus of research in the fields of cancer biology and genetics. It plays a crucial role in maintaining chromosomal integrity, as its dysfunction is often associated with increased chromosomal instability, a hallmark of various cancer types. The study of CHID1 and its recombinant protein form has become pivotal in understanding the underlying mechanisms of tumorigenesis, particularly in relation to DNA damage response pathways. Researchers are exploring CHID1's role not only in the repair of DNA lesions but also in the regulation of cell cycle checkpoints. By investigating the biochemical properties and interactions of the recombinant CHID1 protein, scientists aim to elucidate its function in cellular processes and its potential as a therapeutic target. Understanding CHID1's molecular mechanisms could provide insights into novel strategies for cancer treatment and prevention, particularly in tumors characterized by chromosomal abnormalities. Moreover, the study of CHID1 recombinant protein may also offer valuable information about its potential implications in other diseases related to genomic instability. Thus, ongoing research into CHID1 is pivotal for the advancement of targeted cancer therapies and improving our understanding of cellular responses to genomic insults.
